PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1.56
0.040 2.564%
Share volume: 5,152,488
Last Updated: 03-04-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.52
0.04
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-09-2024 | 03-17-2025 | 05-12-2025 | 08-07-2025 | 11-06-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 1.670 B | 1.509 B | 1.450 B | 1.260 B | 860.789 M | 825.470 M | 803.158 M | 784.083 M | |
| Current Assets | 677.024 M | 628.139 M | 584.234 M | 495.681 M | 444.923 M | 413.397 M | 394.236 M | 375.052 M | |
| Inventories | 67.343 M | 68.594 M | 65.737 M | 58.755 M | 54.007 M | 53.839 M | 53.153 M | 49.285 M | |
| Other Current Assets | 17.144 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 17.144 M | 410.276 M | 393.165 M | 334.561 M | 284.603 M | 259.932 M | 242.187 M | 215.799 M | |
| Total Receivables | 30.323 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 561.914 M | 99.526 M | 77.982 M | 55.370 M | 58.507 M | 54.803 M | 56.467 M | 63.707 M | |
| Total Non-current Assets | 992.896 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 37.291 M | 34.910 M | 31.952 M | 30.505 M | 24.794 M | 23.102 M | 22.127 M | 24.146 M | |
| Other Assets | 10.119 M | 846.442 M | 833.866 M | 734.261 M | 391.072 M | 388.971 M | 386.795 M | 384.885 M | |
| Intangible Assets | 450.131 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 462.261 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.670 B | 1.509 B | 1.450 B | 1.260 B | 860.789 M | 825.470 M | 803.158 M | 784.083 M | |
| Total liabilities | 1.021 B | 1.017 B | 996.930 M | 753.853 M | 769.151 M | 763.981 M | 767.068 M | 778.734 M | |
| Total current liabilities | 72.951 M | 78.390 M | 59.997 M | 66.299 M | 66.602 M | 59.754 M | 63.209 M | 72.831 M | |
| Accounts Payable | 21.006 M | 17.488 M | 12.064 M | 16.590 M | 14.037 M | 15.055 M | 16.362 M | 20.770 M | |
| Other liabilities | 26.358 M | 39.851 M | 38.334 M | 34.160 M | 50.480 M | 52.082 M | 54.300 M | 56.592 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 892.545 M | 892.844 M | 893.144 M | 647.494 M | 646.214 M | 646.436 M | 645.159 M | 645.382 M | |
| Other liabilities | 26.358 M | 39.851 M | 38.334 M | 34.160 M | 50.480 M | 52.082 M | 54.300 M | 56.592 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 649.017 M | 492.700 M | 453.122 M | 506.594 M | 91.638 M | 61.489 M | 36.090 M | 5.349 M | |
| Common stock | 269.578 M | 2.584 B | 2.603 B | 2.655 B | 2.666 B | 2.678 B | 2.691 B | 2.700 B | |
| Retained earnings | -1.917 B | -2.091 B | -2.151 B | -2.149 B | -2.575 B | -2.617 B | -2.655 B | -2.695 B |